Not applicableEnded earlyNCT01369433
What this trial is testing
A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols
Who this might be right for
Solid Tumors
AVEO Pharmaceuticals, Inc. 225